Related Experiment Video
Updated: Aug 19, 2025

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023
In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy
Zheng Li1,2, Jianhua Zou1,2, Xiaoyuan Chen1,2,3,4
1Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 119074, Singapore.
Abstract:
Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn increasing attention, bringing great opportunities for clinical application. Here, two targeting strategies for four main subcellular organelles (mitochondria, lysosome, endoplasmic reticulum, and nucleus), including molecule- and nanomaterial (inorganic nanoparticles, micelles, organic polymers, and others)-based targeted delivery or therapeutic strategies, are summarized. Phototherapy, chemotherapy, radiotherapy, immunotherapy, and "all-in-one" combination therapy are among the strategies covered in detail. Such materials are constructed based on the specific properties and relevant mechanisms of organelles, enabling the elimination of tumors by inducing dysfunction in the corresponding organelles or destroying specific structures. The challenges faced by organelle-targeting cancer therapies are also summarized. Looking forward, a paradigm for organelle-targeting therapy with enhanced therapeutic efficacy compared to current clinical approaches is envisioned.
Insights
Subcellular targeted cancer therapy utilizes molecules and nanomaterials to target specific organelles, offering new anticancer treatment strategies. This approach aims to enhance therapeutic efficacy by exploiting organelle properties for tumor elimination.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Subcellular targeted cancer therapy is a rapidly advancing field with significant clinical potential.
- Targeting specific organelles offers a novel approach to cancer treatment by exploiting their unique functions and vulnerabilities.
Purpose of the Study:
- To summarize current strategies for subcellular organelle-targeted cancer therapy.
- To review both molecule- and nanomaterial-based approaches for targeting mitochondria, lysosomes, endoplasmic reticulum, and the nucleus.
Main Methods:
- Review of targeting strategies based on molecular and nanomaterial delivery systems.
- Analysis of therapeutic modalities including phototherapy, chemotherapy, radiotherapy, immunotherapy, and combination therapies.
- Discussion of materials designed based on organelle-specific properties and mechanisms.
Main Results:
- Two main targeting strategies for four key subcellular organelles are detailed.
- Various therapeutic approaches, including combination therapies, are presented.
- Materials are designed to induce organelle dysfunction or structural destruction for tumor elimination.
Conclusions:
- Organelle-targeting cancer therapies hold promise for enhanced efficacy.
- Challenges in current organelle-targeting strategies are identified.
- A future paradigm for improved cancer treatment through organelle targeting is envisioned.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Tumor Immunotherapy
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...